Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study
Objective Fruquintinib, a novel anti-angiogenic targeted drug, has gained widespread application in the treatment of metastatic colorectal cancer. This study aims to investigate the impact of the prognostic nutritional index (PNI) on the safety and survival outcomes of patients undergoing fruquintin...
Saved in:
Main Authors: | Zeng Wang, Sining Zhao, Xuan Zhang, Xinyi Mao, Guonong Yang, Meiqin Yuan, Xiaofang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2024-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/18565.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of Fruquintinib in the Management of Advanced Refractory Metastatic Colorectal Cancer: Design, Development and Potential Place in Therapy
by: Syaj S, et al.
Published: (2024-11-01) -
Case report: Durable response from tegafur/gimeracil/oteracil (S-1) combined with fruquintinib and sintilimab as a third-line treatment for MSS metastatic colorectal cancer with a BRAF V600E mutation
by: Chunxia He, et al.
Published: (2024-12-01) -
The prognostic utility of the ratio of lymphocyte to monocyte in patients with metastatic colorectal cancer: a systematic review and meta-analysis
by: Pingping Mei, et al.
Published: (2025-02-01) -
Prognostic value of the pretreatment Naples prognostic score in patients with colorectal cancer: a systematic review and meta-analysis
by: Hui Liu, et al.
Published: (2025-01-01) -
Halp Score: A Simple and Easily Accessible Index for Predicting Prognosis in Colorectal Cancer Patients
by: Zeynep Güç
Published: (2022-10-01)